Keywords: Roux-en-Y Gastric Bypass Surgery; Hyperinsulinemic Hypoglycemia Syndrome; Glucagon-like Peptide 1; Islet Function; A-GB; asymptomatic after gastric bypass; AUC; area under the curve; CON; control subjects; EGP; endogenous glucose production; Ex-9; exendin
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AAV1; adeno-associated virus serotype 1; ACC; American College of Cardiology; ACCELERATE; A Study of Evacetrapib in High-Risk Vascular Disease; ACCORD; Action to Control Cardiovascular Risk in Diabetes; ADA; American Diabetes Association; AMP; adenosine m
Keywords: GLP-1; Incretin hormones; Insulin resistance; Gestational diabetes mellitus and glucose metabolism;
Keywords: Alcohol; Ghrelin; Insulin; GLP-1; PYY; Intravenous alcohol administration;
Keywords: SP; short photoperiod; LP; long photoperiod; RQ; respiratory quotient; WAT; white adipose tissue; GC; glucocorticoid; GLP-1; glucagon-like peptide 1; GiP; glucose dependant insulinotropic polypeptide; Mesocricetus auratus; Torpor bout; Periodic arousal; A
Keywords: Neurodegenerative diseases; Alzheimer's disease; Parkinson's disease; Infection; Incretins; GLP-1; Liraglutide;
Keywords: T2DM; type 2 diabetes mellitus; MI; myocardial infarction; CAD; coronary artery disease; I R injury; ischemia reperfusion injury; LV; left ventricle; DPP-4; dipeptidyl peptidase-4; GLP-1; glucagon-like peptide-1; PPARs; peroxisome proliferators-activated
Keywords: GLP-1; GLP-2; Endocannabinoids; Metabolic endotoxaemia; Gut permeability; Prebiotics; Diabetes;
Keywords: ANOVA; analysis of variance; BBB; blood-brain barrier; BHB; beta-hydroxybutyrate; DIO; diet-induced obese; DR; diet resistant; EDTA; ethylenediaminetetraacetic acid; FN; feature negative; GLP-1; glucagon-like peptide-1; HE; high energy; KETO; ketogenic;
Keywords: DPP-4; dipeptidyl peptidase-4; GLP-1; glucagon-like peptide-1; IRS-2; insulin receptor substrate-2; CREB; cAMP response element-binding protein; Gck; glucokinase; GIR; glucose infusion rate(s); EGP; endogenous glucose production; Rd; rate of glucose disap
Keywords: ER; endoplasmic reticulum; UPR; unfolded protein response; PERK; double-stranded RNA-activated protein kinase (PKR)-like ER kinase; ATF-6; activating transcription factor 6; IRE1; inositol requiring enzyme 1; Bip; luminal binding protein (also known as GR
Keywords: ATF-4; activating transcription factor-4; ARNT; aryl hydrocarbon receptor nuclear translocator; bHLH; basic helix-loop-helix; BBB; Basso, Beattie, and Bresnahan; cFLIP; cellular FLICE-inhibitory protein; cyt C; cytochrome C; Cygb; cytoglobin; CYP2B6; cyto
Keywords: ARDS; acute respiratory distress syndrome; Asn; asparagine; BSA; bovine serum albumin; CD; cyclodextrin; COPD; chronic obstructive pulmonary disease; dae; diameter of the particles; DPI; dry powder inhaler; DPPC; dipalmitoylphosphatidylcholine; DSPC; dist
Keywords: GLP-1; Adiponectin; Linker engineering; Diabetes
Keywords: GLP-1; GLP-1R; Amphetamine reinforcement; Alcohol intake; Hedonic feeding
Keywords: Chemotherapy; Nausea; Illness; Vomiting; Emesis; GLP-1
Keywords: GLP-1; Diabetes; Enteroendocrine L-cell; GPCR structure prediction; Virtual ligand screening; Gut receptors
Keywords: Non-alcoholic fatty liver disease; GLP-1; ThiazolidinedionesEsteatosis hepática no alcohólica; Glucagon-like peptide-1; Tiazolidindionas
Keywords: GLP-1; Exendin-4; Corticosterone; Anti-dopamine-β-hydroxylase-saporin; Hypothalamus; Neuropeptide Y
Keywords: Diabetes type 2; GLP-1; Liraglutide; Overweight; Insulin injections
Keywords: GLP-1; Taste preference; Food choice; Weight loss; Roux-en-Y gastric bypass;
The role of SIRT1 in diabetic retinopathy
Keywords: SIR2; Silent Information Regulator2; HDACs; histone deacetylaser; NAD+; nicotinamide adenine dinucleotide; DM; diabetes mellitus); AGEs; advanced glycation end products; AMPK; adenosine monophosphate-activated protein kinas; TGFβ1; transforming growth fa
Geniposidic acid upregulates atrial natriuretic peptide secretion and lowers blood pressure in spontaneously hypertensive rats
Keywords: ANP; atrial natriuretic peptide; ELE; Eucommia leaf extract; GEA; geniposidic acid; GLP-1; glucagon-like peptide-1; GLP-1R; glucagon-like peptide-1 receptor; HR; heart rate; SBP; systolic blood pressure; SHR; spontaneously hypertensive rats; EDTA; ethylen
Analysis of peripheral ghrelin signaling via the vagus nerve in ghrelin receptor-restored GHSR-null mice
Keywords: CNS; central nervous system; GLP-1; glucagon-like peptide-1; GHSR; growth hormone secretagogue receptor; NTS; nucleus tractus solitarii; NPY; neuropeptide Y; AgRP; agouti-related peptide; TBC; transcriptional blocking cassette; Ghrelin; GHSR; Nodose gangl
Secretion of GLP-1 but not GIP is potently stimulated by luminal d-Allulose (d-Psicose) in rats
Keywords: GLP-1; GIP; Allulose; GLP-1; glucagon-like peptide-1; GIP; Glucose-dependent insulinotropic polypeptide; Allulose; d-Allulose; GLUT5; glucose transporter 5; SGLT; sodium-dependent glucose cotransporter;
Co-administration of APD668, a G protein-coupled receptor 119 agonist and linagliptin, a DPPIV inhibitor, prevents progression of steatohepatitis in mice fed on a high trans-fat diet
Keywords: GPR119 agonist; GLP-1; DPPIV inhibitor; Dyslipidemia; NASH; NASH; Non-alcoholic steatohepatitis; NAFLD; Non-alcoholic fatty liver disease; GLP-1; Glucagon-Like Peptide-1; GIP; Gastric Inhibitory Peptide; DPPIV; Dipeptidyl Peptidase IV; MCP-1; Monocyte che
GLP-1 receptor agonists show neuroprotective effects in animal models of diabetes
Keywords: GLP-1; GIP; Brain; Neurons; Growth factors; Neurodegeneration; Inflammation;
Evaluation of 18F-labeled exendin(9-39) derivatives targeting glucagon-like peptide-1 receptor for pancreatic β-cell imaging
Keywords: BCM; β-cell mass; BH-Ex(9-39); Bolton-Hunter labeled exendin(9-39); DMF; N,N-dimethylformamide; FB; Fluorobenzoyl; GFP; Green fluorescent protein; GLP-1; Glucagon-like peptide-1; GLP-1R; Glucagon-like peptide-1 receptor; %ID/g; Percent injected dose per
Investigation of medicinal plants from Madagascar against DPP-IV linked to type 2 diabetes
Keywords: DMSO; dimethyl sulfoxide; DPP-IV; dipeptidyl peptidase-IV; GIP; glucose-dependent insulinotropic polypeptide; GLP-1; glucagon-like peptide 1; GPPN; Gly-pro-p-nitroanilide; HPLC; high-performance liquid chromatography; HR; high resolution; HRMS; high-resol
Effect of yerba mate (Ilex paraguariensis) extract on the metabolism of diabetic rats
Keywords: C group; Control group; CM group; Control with treatment group; D group; diabetes group; DM group; diabetes with treatment group; STZ; streptozotocin; RAT; retroperitoneal adipose tissue; EAT; epidydimal adipose tissue; SM; soleus muscle; L; liver; 14C; c
Glucagon like peptide-1 (GLP-1) likes Alzheimer's disease
Keywords: GLP-1; Alzheimer's disease; Diabetes; Nervous system;
Post-treatment with the GLP-1 analogue liraglutide alleviate chronic inflammation and mitochondrial stress induced by Status epilepticus
Keywords: Liraglutide; GLP-1; Apoptosis; Inflammation; Neuroprotection; Insulin;
Peptide degradation and the role of DPP-4 inhibitors in the treatment of type 2 diabetes
Keywords: DPP-4; dipeptidyl peptidase-4; GIP; glucose-dependent insulinotropic polypeptide; GLP-1; glucagon-like peptide-1; GRP; gastrin-releasing peptide; NEP; neutral endopeptidase; OXM; oxyntomodulin; PACAP; pituitary adenylate cyclase-activating polypeptide; PY
Evaluation of the insulinotropic and glucose-lowering actions of zebrafish GIP in mammalian systems: Evidence for involvement of the GLP-1 receptor
Keywords: Type 2 diabetes; Zebrafish; GIP; GLP-1; Glucagon; Evolution;
GLP-1 receptor agonist liraglutide exerts central action to induce β-cell proliferation through medulla to vagal pathway in mice
Keywords: Glucagon-like peptide-1; Glucose metabolism; Vagus nerve; Liraglutide; Brain stem; Pancreatic β-cell proliferation; AP; Area postrema; ARC; Arcuate nucleus; AChR; Acetylcholine receptor; α-MSH; Alpha-melanocyte-stimulating hormone; BBB; Blood brain barr
Effects of oat β-glucan consumption at breakfast on ad libitum eating, appetite, glycemia, insulinemia and GLP-1 concentrations in healthy subjects
Keywords: Oat β-glucan; Energy intake; Satiety; GLP-1; Glucose; Insulin;
Irish Cheddar cheese increases glucagon-like peptide-1 secretion in vitro but bioactivity is lost during gut transit
Keywords: AA; amino acid; AEBSF; 4-(2-Aminoethyl)benzenesulfonyl fluoride hydrochloride; BCA; bicinchoninic acid; CCK; cholecystokinin; DMEM; Dulbecco's modified eagle medium; DPP-IV; dipeptidyl peptidase IV; GC; gas chromatography; GLP-1; glucagon-like peptide-1
Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer's and Parkinson's disease models
Keywords: Insulin; Neurodegeneration; Inflammation; Growth factors; GIP; GLP-1;
A role for Glucagon-Like Peptide-1 in the regulation of β-cell autophagy
Keywords: Akt; protein kinase B; Ambra1; Autophagy And Beclin 1 Regulator 1; AMPK; 5â² AMP-activated protein kinase; Atg; autophagy related proteins; CAMKK; Ca2+/calmodulin-dependent protein kinase kinase; DFCP1; double FYVE-containing protein 1; DPP4; dipeptidyl
GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgrâ/â mice and is dispensable for the metabolic benefits ensuing after vertical sleeve gastrectomy
Keywords: Glucagon; GLP-1; GLP-2; Bile acids; Bariatric surgery; Glucose; Diabetes; Obesity;
An incretin-based tri-agonist promotes superior insulin secretion from murine pancreatic islets via PLC activation
Keywords: Tri-agonist; Signaling cascade; Pancreatic islets; Insulin secretion; G proteins; TRP channels; AC; Adenylyl cyclase; cAMP; Cyclic adenosine monophosphate; ECL; Extracellular loop; EPAC; Exchange protein directly activated by cAMP; FCS; Fetal calf serum;
Apelin-13 analogues show potent in vitro and in vivo insulinotropic and glucose lowering actions
Keywords: APJ; apelin receptor; CCK; cholecystokinin; DIO; diet induced obese; DPP; 4 dipeptidylpeptidase-4; GIP; glucose-dependent insulinotropic polypeptide; GLP-1; glucagon-like peptide-1; KRB; krebs ringer bicarbonate; pGlu; pyroglutamyl; SGLT-2; sodium glucose
Chitosan oligosaccharides improve the disturbance in glucose metabolism and reverse the dysbiosis of gut microbiota in diabetic mice
Keywords: ACC-1; acetyl-CoA carboxylase 1; AMPK; 5Ⲡadenosine monophosphate-activated protein kinase; CD11c; integrin subunit alpha X; COS; chitosan oligosaccharides; C/EBPα; CCAAT-enhancer-binding protein alpha; GLP-1; glucagon-like peptide-1; H&E; hematoxylin
Immune and metabolic alterations in first episode psychosis (FEP) patients
Keywords: FEP; Cytokines and chemokines; Metabolic markers; IL-8; MIP-1b/CCL4; Ghrelin; Glucagon; VEGF; GLP-1;
Apelin, a promising target for Alzheimer disease prevention and treatment
Keywords: Alzheimer disease; Apelin; Amyloid beta; Central nervous system; Oxidative stress; AAA; Abdominal aortic aneurysm; ABCA1; ATP-binding cassette transporter A1; ACE; Angiotensin converting enzyme; ACh; Acetylcholine; AChE; Acetyl choline esterase; AD; Alzhe
Novel fatty acid chain modified GLP-1 derivatives with prolonged in vivo glucose-lowering ability and balanced glucoregulatory activity
Keywords: GLP-1; Diabetes; Fatty acid; Body weight;
Mechanistic insights into the detection of free fatty and bile acids by ileal glucagon-like peptide-1 secreting cells
Keywords: GLP-1; FFA1; GPBAR1; Organoid; Diabetes; Obesity;
Novel peptide inhibitor of dipeptidyl peptidase IV (Tyr-Pro-D-Ala-NH2) with anti-inflammatory activity in the mouse models of colitis
Keywords: AMC; aminomethylcoumarin; CD; Crohn's disease; DIP; diprotin; DMSO; dimethyl sulfoxide; DPP; IV dipeptidyl peptidase IV; DSS; dextran sulfate sodium; EM-2; endomorphin-2; GAPDH; glycerylaldehyde-3-phosphate dehydrogenase; GI; gastrointestinal; GLP-1; gl
The Period protein homolog LIN-42 regulates germline development in C. elegans
Keywords: LIN-42; GLP-1; LAG-2; ATX-2;
Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces hepatic steatosis and endoplasmic reticulum stress by inducing nuclear factor erythroid-derived 2-related factor 2 nuclear translocation
Keywords: Glucagon-like peptide-1; Exendin-4; Nuclear factor erythroid-derived 2-related factor 2; Endoplasmic reticulum stress; Nonalcoholic fatty liver disease; ATF6; Activation transcription factor-6; Bip; Binding immunoglobulin protein; CHOP; C/EBP homologous p